TNF and rheumatoid arthritis: Among the RA patients with HCV, the hsa-mir-122-5p expression level was dramatically increased in patients treated with RTX (4.51 ± 1.92-fold) or TNF-α inhibitor (1.65 ± 0.33-fold) as compared with those receiving non-biologic agents.